RxDoctor Payments Data

Alexander Lund, DO

Otolaryngology · Flagstaff, AZNPI 1376819417

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (48.5%), travel and lodging and education — rather than concentrated in one kind of arrangement. 17 manufacturers reported payments, led by Intersect ENT, Inc. at 50.2% of the total. Reporting peaked in 2019 at $3,297 and has fallen 84.5% since, to $512 in 2025.

$4,584in general payments, 2019–2025

Across 72 payments — averaging $63.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Intersect ENT, Inc.$2K
  • Medical Device Business Services, Inc.$774
  • Sanofi$530
  • Acclarent, Inc$234
  • Sanofi-aventis U.S. LLC$153
  • GSK$122
  • plus $471 from 11 others

What the payments were for

  • Speaking & faculty fees$351%
  • Travel & lodging$2,17247%
  • Food & beverage$2,22449%
  • Education$1533%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,584 in reported general payments places this provider in the 80th percentile of 150 otolaryngology providers in Arizona.

See all otolaryngology providers in Arizona

Medicare billing

Part B allowed, 2024
$188,696
Medicare patients
552
Services billed
6,286

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ipratropium Bromide171$4,706
Epinephrine22$3,461
Azelastine Hcl40$1,544
Ofloxacin26$615
Fluticasone Propionate55$611
Levothyroxine Sodium62$486
Mupirocin47$310
Omeprazole26$299
Montelukast Sodium27$197
Famotidine33$151
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav17$137
Methylprednisolone19$134
Cephalexin25$125
Nystatin11$104
Prednisone31$62

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Flagstaff

See the full list for Arizona

Where these figures come from

Is this you, or does something look wrong? →